Methods of Using Labeled Ligands Having Human CD4 Specificity
AssigneeBiotectid GmbH
InventorsFrank Emmrich, Raimund W. Kinne, Rudiger Laub, Ullrich Pigla
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of a labelled ligand having specificity for the human CD4 molecule to produce a diagnostic agent for analysing migration and/or distribution patterns of certain cell populations which comprise CD4-bearing cells in human individuals. In addition the invention concerns a composition which comprises a labelled ligand having specificity for the CD4 molecule and CD4-bearing cells or particles, and a method for determining the extent and progression of diseases in which human CD4-bearing cells are of clinical importance.
Claims24
1-25. (canceled)
A method of making a diagnostic agent for analyzing in vivo a migration or a distribution pattern of human CD4-bearing cells in a human subject, said method comprising the steps of:
- obtaining a ligand having specificity for a human CD4 molecule, wherein the ligand is an antibody fragment or a recombinant antibody fragment, and wherein the antibody fragment is selected from the group consisting of:
- an F(ab′)2 fragment, an Fab′ fragment, and an Fab fragment of the antibody Max.16H5, and wherein the recombinant antibody fragment is selected from the group consisting of:
- an F(ab′) fragment, an Fab′ fragment, and an Fab fragment of the antibody Max.16H5;
- and
- attaching a label to the ligand, thereby forming a diagnostic agent.
A composition containing a labeled ligand having specificity for the CD4 molecule and CD4-bearing cells or particles.
A method for determining the extent and progression of diseases in which human CD4-bearing cells are of clinical importance comprising the steps:
- (a) providing an in vivo analysis of the distribution and/or migration pattern of human CD4-bearing cells in an individual,
- (b) providing a standard in vivo analysis of the distribution and/or migration pattern of human CD4-bearing cells in an individual and
- (c) determining deviations of the analyses provided in step a) and step b) which enable the extent and progression of the disease to be determined.
Dependencies are inferred from the claim text.